Login / Signup

Health care resource utilization and treatment of leptomeningeal carcinomatosis in the United States.

Syed M AdilSarah E HodgesRyan M EdwardsLefko T CharalambousZidanyue YangMusa KiyaniAlexis MusickBeth A ParenteHui-Jie LeeKatherine B PetersPeter E FecciShivanand P Lad
Published in: Neuro-oncology practice (2020)
LC is a devastating condition with an overall poor prognosis. We present the largest study of LC in this real-world study, including current treatments, with an emphasis on HCRU. There is considerable variation in the treatment of LC and significant health care costs.
Keyphrases
  • poor prognosis
  • healthcare
  • long non coding rna
  • mass spectrometry
  • simultaneous determination
  • liquid chromatography
  • combination therapy
  • health insurance
  • high resolution mass spectrometry